Literature DB >> 8978357

The relative roles of hepatitis B and C viruses in the etiology of hepatocellular carcinoma in southern African blacks.

M C Kew1, M C Yu, M A Kedda, A Coppin, A Sarkin, J Hodkinson.   

Abstract

BACKGROUND & AIMS: Epidemiological studies have shown the relative roles of hepatitis B and C viruses in hepatocarcinogenesis to vary considerably among populations. The aim of this study was to define the independent and interactive roles of the two viruses in the genesis of hepatocellular carcinoma in southern African blacks.
METHODS: Blood samples were taken from 231 black patients with hepatocellular carcinoma and matched controls treated at four Johannesburg hospitals. These were tested for hepatitis B surface antigen, antibodies to hepatitis C virus, and hepatitis C virus RNA.
RESULTS: Relative to individuals without serological evidence of hepatitis B or C infection, those positive for hepatitis B surface antigen alone had a statistically significant 23.3-fold increased risk for hepatocellular carcinoma, whereas those positive for hepatitis C serology alone had a statistically significant risk of 6.6. A synergistic effect on risk was evident when both hepatitis B and C markers were present (relative risk, 82.5). Hepatitis B virus alone is estimated to cause 43% of hepatocellular carcinoma in southern African blacks, hepatitis C alone 5%, and coinfection with the two viruses 20%.
CONCLUSIONS: Hepatitis B virus plays a predominant role in hepatocellular carcinogenesis in southern African blacks, with hepatitis C virus responsible for a smaller proportion of cases. Coinfection with the two viruses carries a synergistic risk of hepatocellular carcinoma formation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8978357     DOI: 10.1016/s0016-5085(97)70233-6

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  24 in total

1.  Liver iron excess in patients with hepatocellular carcinoma developed on viral C cirrhosis.

Authors:  C Chapoutot; M Esslimani; Z Joomaye; J Ramos; P Perney; C Laurent; P Fabbro-Peray; D Larrey; J Domergue; F Blanc
Journal:  Gut       Date:  2000-05       Impact factor: 23.059

2.  Clinical guidelines on the management of hepatitis C.

Authors:  J C Booth; J O'Grady; J Neuberger
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

3.  Immunization needs of chronic liver disease patients seen in primary care versus specialist settings.

Authors:  R Jake Jacobs; Allen S Meyerhoff; Sammy Saab
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

4.  Prognostic factors associated with hepatitis C disease: a case-control study utilizing U.S. multiple-cause-of-death data.

Authors:  Matthew Wise; Lyn Finelli; Frank Sorvillo
Journal:  Public Health Rep       Date:  2010 May-Jun       Impact factor: 2.792

Review 5.  Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy.

Authors:  Mindie H Nguyen; Grace Wong; Edward Gane; Jia-Horng Kao; Geoffrey Dusheiko
Journal:  Clin Microbiol Rev       Date:  2020-02-26       Impact factor: 26.132

6.  Hepatocellular carcinoma in Lebanon: Etiology and prognostic factors associated with short-term survival.

Authors:  Cesar Yaghi; Ala-I Sharara; Paul Rassam; Rami Moucari; Khalil Honein; Joseph BouJaoude; Rita Slim; Roger Noun; Heitham Abdul-Baki; Mohamad Khalifeh; Sami Ramia; Raymond Sayegh
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

7.  Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progression.

Authors:  Rosa Zampino; Nicola Coppola; Grazia Cirillo; Adriana Boemio; Carmine Minichini; Aldo Marrone; Maria Stanzione; Mario Starace; Emanuele Durante-Mangoni; Evangelista Sagnelli; Luciano Restivo; Giovanna Salzillo; Maria Chiara Fascione; Riccardo Nevola; Emanuele Miraglia Del Giudice; Luigi Elio Adinolfi
Journal:  World J Hepatol       Date:  2014-09-27

8.  Aromatase (CYP19) promoter gene polymorphism and risk of nonviral hepatitis-related hepatocellular carcinoma.

Authors:  Woon-Puay Koh; Jian-Min Yuan; Renwei Wang; Sugantha Govindarajan; Rowena Oppenheimer; Zhen Quan Zhang; Mimi C Yu; Sue Ann Ingles
Journal:  Cancer       Date:  2011-02-11       Impact factor: 6.860

Review 9.  Regulatory mechanisms of viral hepatitis B and C.

Authors:  G Waris; A Siddiqui
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

10.  Hepatitis C virus genotype 3a infection and hepatocellular carcinoma: Pakistan experience.

Authors:  Muhammad Idrees; Shazia Rafique; Irshadur Rehman; Haji Akbar; Muhammad-Zubair Yousaf; Sadia Butt; Zunaira Awan; Sobia Manzoor; Madiha Akram; Mahwish Aftab; Bushra Khubaib; Sheikh Riazuddin
Journal:  World J Gastroenterol       Date:  2009-10-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.